Skip to main content
. 2011 Sep 14;3(3):3585–3600. doi: 10.3390/cancers3033585

Figure 5.

Figure 5.

Comparison of biochemical failure-free control rate between the intermediate-risk group treated by HDR + EBRT and patients treated by radical prostatectomy.